Genomic landscape of colorectal carcinogenesis Jin Cheon KimWalter F. Bodmer Review – Cancer Research 20 January 2022 Pages: 533 - 545
Regulatory effects of lncRNAs and miRNAs on the crosstalk between autophagy and EMT in cancer: a new era for cancer treatment Lihui SiZecheng YangDuoduo Zhang Review – Cancer Research 27 January 2022 Pages: 547 - 564
NRAS expression is associated with prognosis and tumor immune microenvironment in lung adenocarcinoma Yueren YanZhendong GaoHaiquan Chen Original Article – Cancer Research 08 November 2021 Pages: 565 - 575
Horizontal tumor extent (HZTE) has limited prognostic significance in 2018 FIGO stage I endocervical adenocarcinoma (ECA): a retrospective study of 416 cases Simona StolnicuLien HoangKay J. Park Original Article – Cancer Research 12 November 2021 Pages: 577 - 586
Vasculogenic mimicry correlates to presenting symptoms and mortality in uveal melanoma Shiva SabazadeViktor GillGustav Stålhammar Original Article – Cancer Research Open access 13 November 2021 Pages: 587 - 597
Expressions and significances of CTSL, the target of COVID‐19 on GBM Qiang DongQiao LiYawen Pan Original Article – Cancer Research 22 November 2021 Pages: 599 - 608
Overexpression of melanoma-associated antigen A2 has a clinical significance in embryonal carcinoma and is associated with tumor progression Leili Saeednejad ZanjaniMahdieh RazmiMonireh Mohsenzadegan Original Article – Cancer Research 27 November 2021 Pages: 609 - 631
Targeting abundant survivin expression in liposarcoma: subtype dependent therapy responses to YM155 treatment Christian VayPhilipp M. SchlünderAndreas Krieg Original Article – Cancer Research Open access 03 December 2021 Pages: 633 - 645
Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients Mette-Triin PurdeRebekka NiedererLukas Flatz Original Article – Cancer Research Open access 07 December 2021 Pages: 647 - 656
Solitary colorectal liver metastasis: overview of treatment strategies and role of prognostic factors S. AcciuffiF. MeyerA. Altendorf-Hofmann Review – Clinical Oncology Open access 16 December 2021 Pages: 657 - 665
Treatment and follow-up of rare testis tumours Christian Daniel FankhauserJosias Bastian GroggNoel William Clarke Review – Clinical Oncology 20 January 2022 Pages: 667 - 671
A multicenter clinical study: personalized medication for advanced gastrointestinal carcinomas with the guidance of patient-derived tumor xenograft (PDTX) Yuan ChengShu-kui QinYan-ping Zhu Original Article – Clinical Oncology 17 April 2021 Pages: 673 - 684
Application of circulating genetically abnormal cells in the diagnosis of early-stage lung cancer Xiaochang QiuHaoran ZhangDianjie Lin Original Article – Clinical Oncology 24 April 2021 Pages: 685 - 695
Hormonal tumor mapping for liver metastases of gastroenteropancreatic neuroendocrine neoplasms: a novel therapeutic strategy Aya MaekawaAtsushi KudoMinoru Tanabe Original Article – Clinical Oncology 27 April 2021 Pages: 697 - 706
Real-life drug–drug and herb–drug interactions in outpatients taking oral anticancer drugs: comparison with databases H. PrelyC. HerledanC. Rioufol Original Article – Clinical Oncology 29 April 2021 Pages: 707 - 718
Trastuzumab treatment of patients with early, HER2-positive breast cancer in 17 certified German breast cancer centers Nora Tabea SibertSimone WesselmannOlaf Ortmann Original Article – Clinical Oncology 29 April 2021 Pages: 719 - 726
Biopsy-detected Gleason grade 5 tumor is an additional prognostic factor in metastatic hormone-sensitive prostate cancer Bumjin LimWonchul LeeChoung-Soo Kim Original Article – Clinical Oncology 04 May 2021 Pages: 727 - 734
Analysis of end-of-life treatment and physician perceptions at a university hospital in Germany Nicole HeerdeWolf-Karsten HofmannDeniz Gencer Original Article – Clinical Oncology Open access 05 May 2021 Pages: 735 - 742
Blastic plasmacytoid dendritic-cell neoplasia: a challenging case report Ruth-Miriam KoerberStefanie A. E. HeldAnnkristin Heine Letter to the Editor Open access 16 September 2021 Pages: 743 - 748
Correction to: MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1 Xin-Long MaFeng ShangYu-Qi Zhang Correction 19 November 2021 Pages: 749 - 750
Correction to: Inactivation of ICAM1 inhibits metastasis and improves the prognosis of Ewing’s sarcoma Bin PanXiangbo BuKaijin Guo Correction 06 January 2022 Pages: 751 - 751